Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

INTRODUCTION. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. METHODS. A post hoc analysis of the efficacy and tolerability...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AlphaMed Press 2013
Pynciau:
Gastrointestinal Cancer
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556255/
https://ncbi.nlm.nih.gov/pubmed/23263288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0263
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg